| 发明名称 | Treatment of inflammatory bowel diseases with mammal beta defensins | ||
| 摘要 | The present invention relates to treatment of inflammatory bowel diseases with mammal beta defensins. | ||
| 申请公布号 | US8802621(B2) | 申请公布日期 | 2014.08.12 |
| 申请号 | US201113158638 | 申请日期 | 2011.06.13 |
| 申请人 | Defensin Therapeutics ApS | 发明人 | Kjaer Tanja Maria Rosenkilde;Kruse Thomas;Mygind Per Holse;Brinch Karoline Sidelmann;Kjaerulff Soeren;Andersen Birgitte |
| 分类号 | A61K38/00;A61P31/04;A61K38/17 | 主分类号 | A61K38/00 |
| 代理机构 | Hamilton, Brook, Smith & Reynolds, P.C. | 代理人 | Hamilton, Brook, Smith & Reynolds, P.C. |
| 主权项 | 1. A method of treating an inflammatory bowel disease, the method comprising administering orally to a subject in need of such treatment an effective amount of a human beta defensin comprising an amino acid sequence having at least 95% identity to the amino acid sequence of SEQ ID NO: 2, wherein the inflammatory bowel disease is Crohn's disease of the colon. | ||
| 地址 | Gentofte DK | ||